Ultralytics, a global leader in vision AI at the edge, has completed a $30 million Series A funding round led by Elephant with participation from SquareOne .

iPETcertum™, recently cleared by the US FDA, will be distributed in Brazil by New Vida Medicamentos e Productos Ltda., a wholly owned subsidiary of Claritas NucMed Brazil, and an approved distributor ...